R. Di Marco et al., Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): Suppression of IFN-gamma and TNF-alpha and enhancement of IL-10, J AUTOIMMUN, 13(2), 1999, pp. 187-195
The immunomodulating antibiotic drug fusidic acid and its sodium salt sodiu
m fusidate (fusidin) ameliorate several organ-specific immunoinflammatory d
iseases. Because preliminary observations suggest that fusidin may also exe
rt a beneficial effect in Guillain-Barre syndrome (GBS), here we have studi
ed the effects of fusidin on actively induced experimental autoimmune neuri
tis (EAN) in rats, a known animal model for GBS. Both prophylactic and ther
apeutic treatment with fusidin (4 mg/rat day ip) markedly ameliorated the c
linical course of the disease compared to vehicle-treated animals. The bene
ficial effects were associated with profound modifications of the capacity
of these rats to produce and release pro- and anti-inflammatory cytokines s
uch as IFN-gamma, TNF-alpha and IL-10, which are important in regulating th
e development of EAN. (C) 1999 Academic Press.